He received formal training in infectious diseases and molecular mechanisms of pathogenesis and has more than 15 years of experience directing global product development and registration programs. He also has extensive experience in pharmacovigilance and health informatics as well as the evaluation and exchange of safety data. He has served with other experts and senior scientists on many consensus panels, including ICH, CIOMS, ISO, and HL7.

Dr Sidney Kahn has been involved in pharmacovigilance activities for over 17 years, including PhRMA representation on ICH EWGs, CIOMS-VI, DIA SIACs for Labeling, CSP, Terminology Management, and the HL7 SPL WG. Dr. Kahn is a frequent presenter in the USA and Europe on all aspects of drug safety.